Skip to content
healthcare.dev
Get a free key

Cytarabine

NDC 61703-155, CYTARABINE, injection, solution, from Hospira, Inc..

Product NDC
61703-155
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075383
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61703-155 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYTARABINE100 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
61703-155-01617030155011 VIAL, SINGLE-DOSE in 1 CARTON (61703-155-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e3a8c0e9-19ed-49b7-8464-11e8806f47fd

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61703-155

Use it

Look up 61703-155 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61703-155 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61703-155. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.